New Issue: UBS prices $100,000 airbag yield optimization notes linked to Vertex Pharmaceuticals

New York, June 19 – UBS AG, London Branch priced $100,000 of 10.21% airbag yield optimization notes due June 24, 2015 linked to the common stock of Vertex Pharmaceuticals Inc., according to a 424B2 filing with the Securities and Exchange Commission.

Interest is payable monthly.

The payout at maturity will be par unless the final share price is less than the conversion price, in which case the payout will be a number of Vertex Pharmaceuticals shares equal to $1,000 divided by the conversion price. The conversion price is 75% of the initial share price.

UBS Financial Services Inc. and UBS Investment Bank is the agent.

Issuer:	UBS AG, London Branch
Issue:	Airbag yield optimization notes
Underlying stock:	Vertex Pharmaceuticals Inc.
Amount:	$100,000
Maturity:	June 24, 2015
Coupon:	10.21%, payable monthly
Price:	Par
Payout at maturity:	If final share price is less than conversion price, number of Vertex Pharmaceuticals shares equal to $1,000 divided by conversion price; otherwise, par
Initial share price:	$64.63
Conversion price:	$48.47, 75% of initial price
Pricing date:	June 19
Settlement date:	June 24
Underwriters:	UBS Financial Services Inc. and UBS Investment Bank
Fees:	2%
Cusip:	90272M285

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.